Northrop Realty opens first office in Harford County

CLARKSVILLE, Md. (PRWEB) December 13, 2019

Northrop Realty, A Long & Foster Company, is opening an office in Fallston located at 2309 Belair Road, Suite B, the residential real estate brokerage’s first office in Harford County. The new 2,500-square-foot office will support 30 real estate agents and team members serving Harford County.

“Harford County is growing tremendously with new homes, neighborhoods, restaurants and shopping,” said Creig Northrop, president and CEO of Northrop Realty. “We’re serving more and more clients in Harford County, and we want to continue providing the absolute best service possible. We’re proud to open a new office, which will let us do just that.”

The Fallston office opening follows a series of new Northrop Realty office openings, including the brokerage’s Fenwick Island, Delaware, office in August, its Frederick, Maryland, office in June and its Ellicott City, Maryland, office in March. Northrop Realty also has offices in Annapolis, Clarksville, Columbia, Silver Spring, Sykesville and Timonium, Maryland, bringing the total number of offices to 10.

Formerly the Creig Northrop Team of Long & Foster Real Estate, Northrop Realty became a full-service brokerage within the Long & Foster Real Estate family of companies last year. The transition from real estate team to brokerage allows Northrop Realty to grow its service areas.

The Fallston office’s phone number is 410-770-2910.

About Northrop Realty

Northrop Realty, A Long & Foster Company, has evolved from the No. 1 ranked real estate team in the nation,* the Creig Northrop Team of Long & Foster Real Estate. The brokerage represents buyers and sellers of residential real estate in the Baltimore and Washington metropolitan regions with offices throughout Maryland and Delaware. Creig and Carla Northrop have more than 25 years of experience in real estate and lead a Company of more than 200 licensed real estate professionals. (http://www.northroprealty.com)

*By sales volume, according to the REAL Trends 1000

Read the full story at https://www.prweb.com/releases/northrop_realty_opens_first_office_in_harford_county/prweb16787481.htm

Opting for Optimus – Cognizin® Citicoline Featured in New Drinkable Nootropic Supplement

NEW YORK (PRWEB) December 13, 2019

Nootropic supplement brand Nustait enters the market with its first product launch Optimus, a non-GMO, vegan, gluten-free drinkable nootropic supplement curated with research-backed ingredients for cognitive support, available in a lemon tea flavor.

Optimus, designed to be fast-acting and long-lasting, is a potent nootropic containing the equivalent of eleven capsules packed into one single serving, a move that amounted from co-founder Eduardo Casado’s research on nootropics and his desire to combine the hefty eleven capsules he would take per day into one highly effective nootropic formula.

“Knowing that the nootropic field is growing fast, and that there’s a lot of junk out there, people want and need a quality supplement, which is why we decided to create Optimus,” comments Jesse Casado, co-founder of Nustait, “One serving contains the equivalent of 11 pills, which means less money while still receiving high quality, high potency, researched-backed ingredients.”

Optimus’ unique formulation consists of popular nootropic ingredients such as ashwagandha and l-theanine, along with Kyowa Hakko’s patented form of citicoline, Cognizin® Citicoline.

Tested in human clinical trials and developed using an innovative fermentation process, Cognizin® Citicoline is a pure, allergen-free ingredient with GRAS status that’s stable and effective*. Cognizin® Citicoline supports mental energy, focus and attention*, helping to keep the brain’s energy centers firing.*

Kyowa Hakko Bio, health ingredient manufacturer of Cognizin® Citicoline and global leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, is “thrilled to have Cognizin® Citicoline featured as a key component of Nustait’s groundbreaking new product,” remarks Elyse Lovett, Senior Marketing Manager, Kyowa Hakko USA. “Kyowa Hakko is always striving for advancement and innovation within the dietary supplement industry, and Cognizin® Citicoline’s addition into this drinkable nootropic product helps to further this mission,” she adds.

Optimus is available for purchase online at http://www.nustait.com. Media interested in setting up an interview with a representative from Kyowa Hakko USA please contact Sara White at sara@adinnyc.com or 212-693-2150.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

About Cognizin® Citicoline

Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. * Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure and allergen-free. For more information on Cognizin®, visit http://www.Cognizin.com.

About Kyowa Hakko USA

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products. For more information visit http://www.Kyowa-USA.com

Read the full story at https://www.prweb.com/releases/opting_for_optimus_cognizin_citicoline_featured_in_new_drinkable_nootropic_supplement/prweb16788587.htm

Ocean Tomo and Ocean Tomo China Open Call for Network Security Patented Technology

CHICAGO (PRWEB) December 13, 2019

Ocean Tomo and Ocean Tomo China are actively seeking patents and related intangible assets covering network security technology. Cisco’s Visual Networking Index (VNI) projects global IP traffic to more than triple by 2022. Against this backdrop, Ocean Tomo Private Acquisitions is responding to multiple buyers with immediate interest in patents related to authentication, certification, encryption/decryption in networks of both wired and wireless contexts. Technologies of interest include both open systems interconnection, (OSI) layer or cross-layer innovations as well as location-based services (LBS), quantum-based, and block-chain backed inventions.

Ocean Tomo clients seek US, Chinese, Indian and European patents.

Patent owners interested in submitting technology for sale as part of this call for network security patents, can submit them here or to Layna Guo at Transactions@OceanTomo.com.

About Ocean Tomo

Ocean Tomo, the Intellectual Capital Merchant Bank® firm, provides companies with financial services related to intellectual property and intangible assets including financial expert testimony, valuation, strategy consulting, investment advisory, innovation management consulting and transaction brokerage.

Our Opinion, Management, and Advisory Services are built upon more than three decades of experience valuing intellectual property in the most rigorous of venues – State, Federal and international courts. Our financial, market and technical experts provide a unique understanding of the contributory value of proprietary innovation. This is the cornerstone of our business. This insight permeates every practice.

Subsidiaries of Ocean Tomo include Ocean Tomo Investment Group, LLC, a licensed broker-dealer under Federal and State securities law (brokercheck.finra.org Broker Check CRD #: 172912) and Ocean Tomo Hong Kong Ltd., dba, Ocean Tomo China, a joint venture between Ocean Tomo and Sinofaith IP Group.

Read the full story at https://www.prweb.com/releases/ocean_tomo_and_ocean_tomo_china_open_call_for_network_security_patented_technology/prweb16788693.htm